Assure Neuromonitoring - About the company
Assure Neuromonitoring is a late stage company based in Denver (United States), founded in 2015 by Preston Parsons. It operates as a Provider of interoperability neuromonitoring solutions for surgeons. Assure Neuromonitoring has raised an undisclosed amount in funding. The company has 184 active competitors, including 30 funded and 12 that have exited. Its top competitors include companies like HealthVerity, 1upHealth and ESO.
Company Details
Provider of interoperability neuromonitoring solutions for surgeons. It works with neurosurgeons and orthopedic spine surgeons to provide a suite of services that support intraoperative neuromonitoring activities during invasive surgeries.
- Website
- assureneuromonitoring.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2015
Location
Denver, United States
Stage
Late Stage
Latest Funding Round
Investors
Ranked
18th among 184 active competitors
Employee Count
30 as on Sep 30, 2026
Investment & Acquisitions
Similar Companies
Legal entities associated with Assure Neuromonitoring
Assure Neuromonitoring is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
ASSURE NEUROMONITORING, LLC CIN: 32066949507 , United States, Active | Apr 23, 2018 | - | - | - |
ASSURE HOLDINGS CORP CIN: 822726719 , United States, Active | Dec 31, 1999 | - | 100 (As on Dec 31, 2023) | - |
ASSURE HOLDINGS CORP. CIN: 1798270 , United States, Active | - | 127 (As on Dec 31, 2022) | - |
Sign up to download Assure Neuromonitoring's company profile
Assure Neuromonitoring's funding and investors
Assure Neuromonitoring has raised funding over 6 rounds. Its first funding round was on May 08, 2020. Assure Neuromonitoring has 2 institutional investors.
Here is the list of recent funding rounds of Assure Neuromonitoring:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 02, 2022 | 1261642 | Post IPO | 3519976 | 2264949 | 1444792 | 4924982 |
Nov 30, 2020 | 7093079 | Post IPO | 5757777 | 6670283 | 1088843 | 1109029 |
Aug 13, 2020 | 3591628 | Post IPO | 4749799 | 6140206 | 6652531 | 7401136 |
View details of Assure Neuromonitoring's funding rounds and investors
Assure Neuromonitoring's founders and board of directors
Founder? Claim ProfileThe founders of Assure Neuromonitoring is Preston Parsons.
Here are the details of Assure Neuromonitoring's key team members:
- Preston Parsons: Founder of Assure Neuromonitoring.
View details of Assure Neuromonitoring's Founder profiles and Board Members
Assure Neuromonitoring's employee count trend
Assure Neuromonitoring has 30 employees as of Sep 26. Here is Assure Neuromonitoring's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Assure Neuromonitoring's Competitors and alternates
Top competitors of Assure Neuromonitoring include HealthVerity, 1upHealth and ESO. Here is the list of Top 10 competitors of Assure Neuromonitoring, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | HealthVerity 2014, Philadelphia (United States), Series D | Cloud based healthcare and consumer data platform | $142M | 65/100 | |
2nd | 1upHealth 2017, Boston (United States), Series C | Cloud based platform for practice and EHR management | $80.4M | 62/100 | |
3rd | ESO 2004, Austin (United States), Series B | Provider of integrated software for emergency medical services | $50.4M | 61/100 | |
4th | Akido Labs 2015, Los Angeles (United States), Series B | Digital EMR management tool for providers | $95.6M | 58/100 | |
5th | xCures 2018, Oakland (United States), Series B | Developer of an AI-assisted healthcare data platform | $76M | 58/100 | |
6th | Smile Digital Health 2016, Toronto (Canada), Series B | Provider of health data integration solutions for the healthcare industry | $50M | 56/100 | |
7th | Kno2 2009, Boise (United States), Series A | Cloud-based electronic clinical document exchange solutions for healthcare organizations | $17M | 55/100 | |
8th | Zivian 2009, Cleveland (United States), Seed | Healthcare SaaS platform facilitating compliant collaborations between nurse practitioners and physicians | $3M | 53/100 | |
9th | OMNY 2017, San Francisco (United States), Late Stage | Developer of a healthcare data platform for pharmaceutical, biotech, and life sciences companies | $17M | 48/100 | |
10th | CareEvolution 2004, Ann Arbor (United States), Funding Raised | Provider of secure interoperability solutions | - | - | 46/100 |
18th | Assure Neuromonitoring 2015, Denver (United States), Late Stage | Provider of interoperability neuromonitoring solutions for surgeons | - | 39/100 |
Looking for more details on Assure Neuromonitoring's competitors? Click here to see the top ones
Assure Neuromonitoring's Investments and acquisitions
Assure Neuromonitoring has not made any investments yet. Assure Neuromonitoring has made 4 acquisitions.Here is the list of latest three $acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jan 06, 2023 | Acquisition | Englewood (United States) | ||
May 03, 2021 | Acquisition | 2007 | Tomball (United States) | |
Mar 15, 2021 | Acquisition | 2018 | Fort Worth (United States) |
See all acquisitions by Assure Neuromonitoring
Reports related to Assure Neuromonitoring
Here is the latest report on Assure Neuromonitoring's sector:
News related to Assure Neuromonitoring
•
Assure Announces Amendment of Exchange Offer Relating to its Convertible NotesBusiness Wire•Sep 07, 2024•Assure Neuromonitoring
•
Assure Announces Further Extension of Exchange Offer Relating to its Convertible NotesGlobeNewswire•Aug 19, 2024•Assure Neuromonitoring
•
Assure Announces Further Extension of Exchange Offer Relating to its Convertible NotesFinancial Post•Jul 29, 2024•Assure Neuromonitoring
•
Assure Announces Reverse Stock Split to support Continued Listing on NASDAQGlobeNewswire•Jul 04, 2024•Assure Neuromonitoring
•
Halper Sadeh LLC Continues to Investigate AKLI, WIRE, CBNK, IONMPR Newswire•Jun 05, 2024•Halper Sadeh, Akili Interactive, Encore Wire, Capital Bank and 1 other
•
Assure Holdings Receives Notification of Delinquency from NasdaqGlobeNewswire•May 29, 2024•Assure Neuromonitoring
•
Halper Sadeh LLC Investigates SQSP, IONM, HRTBenzinga•May 18, 2024•Halper Sadeh, Squarespace, Assure Neuromonitoring, HireRight
•
Halper Sadeh LLC Investigates DCPH, IONM, DPSIPR Newswire•May 10, 2024•Halper Sadeh, DecisionPoint, Assure Neuromonitoring, Deciphera
•
Assure Reminds Stockholders To Vote For The Proposed Increase in Authorized SharesFinancial Post•May 07, 2024•Assure Neuromonitoring
•
Assure Holdings Closes Sale of Certain Assets to MPOWERHealthCalgary Herald•Mar 28, 2024•Assure Neuromonitoring, MPOWERHealth
Are you a Founder ?
FAQs about Assure Neuromonitoring
Explore our recently published companies
- Fat Mascara - 2016 founded, Unfunded company
- Corporate Office - Unfunded company
- Birdcareco Shop - Nailsworth based, 2008 founded, Unfunded company
- Pools And More - Malta based, Unfunded company
- Impresstars - Unfunded company
- Ignitus - Moltiplicatori di Valore - Italy based, 2015 founded, Unfunded company
_1575276583583.png?format=webp&height=120&width=120)
